|

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

RECRUITINGN/ASponsored by University of Eastern Finland
Actively Recruiting
PhaseN/A
SponsorUniversity of Eastern Finland
Started2026-09
Est. completion2027-09
Eligibility
Age45 Years – 55 Years
Healthy vol.Accepted

Summary

PREMAP invites residents of the Eloisa region (South Savo, Finland) turning 45, 50, or 55 years of age in 2026 to undergo a blood-based NMR metabolomics risk assessment for five interlinked cardio-renal-metabolic conditions (type 2 diabetes, coronary heart disease/myocardial infarction, stroke/cardiovascular disease, chronic kidney disease, and fatty liver disease), alongside a mental wellbeing assessment (WHO-5 Well-Being Index). Based on this risk profile, participants are classified as low, moderate, or high multi-disease risk. Participants at moderate or high risk are individually randomized in a 1:1:1 ratio to one of three digital health interventions for up to 12 months: a habit-based lifestyle application (BitHabit), a structured digital lifestyle coaching programme (Onnikka), or a guideline-based digital self-care pathway (Oma Eloisa, comparator). Participants at high risk additionally receive a physician consultation and optimization of guideline-directed medical therapy. All participants, including the non-randomized low-risk group, are followed prospectively at baseline, 6 months, and 12 months. The study evaluates whether early risk identification and risk-stratified digital interventions reduce future disease risk and improve wellbeing and estimates the cost-effectiveness of the overall approach for the Finnish healthcare system.

Eligibility

Age: 45 Years – 55 YearsHealthy volunteers accepted
Inclusion Criteria:

* Permanent resident of the Eloisa Wellbeing Services County (South Savo, Finland), or has selected Eloisa primary health care as their primary public care provider
* Turning 45, 50, or 55 years of age during calendar year 2026
* NMR metabolomics-based risk assessment result classified as low, moderate, or high multi-disease risk
* Able to provide written informed consent digitally
* Able to use a smartphone, tablet, or computer for digital application access
* Resident of Finland with a Finnish personal identity code (required for health register linkage)

Exclusion Criteria:

* Currently pregnant or breastfeeding
* Incarcerated or under forensic psychiatric care
* Significantly impaired capacity for self-determination
* Insufficient proficiency in Finnish to provide informed consent and complete study procedures
* No Finnish personal identity code

Conditions10

Cerebrovascular DiseaseChronic Kidney DiseaseCoronary Heart DiseaseDiabetesFatty Liver DiseaseHeart DiseaseLiver DiseaseMyocardial InfarctionStrokeType 2 Diabetes

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.